Australia plans to stop AstraZeneca vaccine production — but how will it affect our neighbours?
ABCThe federal opposition and aid groups are urging the government to extend its contract with biotech giant CSL to manufacture more AstraZeneca vaccines in Melbourne, saying Australia should ramp up production next year to help vanquish the COVID-19 pandemic. Key points: Around 12.5 million AstraZeneca doses have been administered to Australians, while more than 3.5 million doses have been sent to countries in the Pacific and South-East Asia The government has promised to sent a total of 40 million doses to other countries Reverend Tim Costello says the government should produce more vaccines and sell 50-100 million doses to South-East Asian countries at cost Federal Health Minister Greg Hunt confirmed this morning the government would not renew its contract with CSL beyond the 51 million doses the company had already promised to deliver. Spokesman for the End COVID For All campaign, Reverend Tim Costello, said the government should "invest in production domestic capability to produce 50-100 million vaccines to sell at cost to South-East Asia". It's also committed $100 million to an initiative from the "Quad" countries — the United States, Japan, India and Australia — to roll out around 1.2 billion vaccine doses in the Indo-Pacific. Papua New Guinea Health Minister Jelta Wong said his country had not been "officially informed" about the government's plans for the CSL contract, but said he was confident Australia would "continue to provide vaccines to PNG, whether manufactured in Australia or purchased internationally".